Effect of functional bread rich in potassium, g-aminobutyric acid and angiotensin-converting enzyme inhibitors on blood pressure, glucose metabolism and endothelial function a double-blind randomized crossover clinical trial

Medicine (United States)

Volumn 94, Issue 46, 2015, Pages e1807-

  Becerra Tomas, Nerea ^a,b   Guasch Ferre, Marta ^a,b   Quilez, Joan ^b,c   Merino, Jordi ^d   Ferre, Raimon ^d   Diaz López, Andres ^a,b   Bulló, Monica ^a,b   Hernández Alonso, Pablo ^a,b   Palau Galindo, Antoni ^e   Salas Salvadó, Jordi ^a,b  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT RAMON LLULL   (Spain)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^e Grup SAGESSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; POTASSIUM; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE BLOOD LEVEL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD VESSEL FUNCTION; BREAD; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ENDOTHELIAL FUNCTION; ENDOTHELIUM; FEMALE; FOOD COMPOSITION; FOOD INTAKE; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; LOW SODIUM WHEAT BREAD; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; WHEAT; ADOLESCENT; AGED; BLOOD; DIET THERAPY; FORTIFIED FOOD; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOMARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BREAD; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; FOOD, FORTIFIED; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POTASSIUM; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84948659485     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001807     Document Type: Article

References (48)

1. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009.
2. Lawes CM, Hoorn S, Vander, et al. Global burden of bloodpressure-related disease, 2001. Lancet. 2008;371:1513-1518.
3. MacMahon S, Peto R, Collins R, et al. Blood pressure, stroke, and coronary heart disease. Lancet. 1990;335:765-774.
4. Qureshi AI, Suri MFK, Kirmani JF, et al. Is prehypertension a risk factor for cardiovascular diseases? Stroke. 2005;36:1859-1863.
5. Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:1685-1697.
6. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462-1536.
7. Appel LJ. ASH position paper: dietary approaches to lower blood pressure. J Am Soc Hypertens. 2009;3:321-331.
8. Strazzullo P, D'Elia L, Kandala N-B, et al. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009;339 (nov24-1):b4567.
9. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis. ;49:59-75.
10. Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334:885-888.
11. Powles J, Fahimi S, Micha R, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3:e003733.
12. Quilez J, Salas-Salvado J. Salt in bread in Europe: potential benefits of reduction. Nutr Rev. 2012;70:666-678.
13. Ueno H. Enzymatic and structural aspects on glutamate decarboxylase. J Mol Catal B Enzym. 2000;10:67-79.
14. Thwaites DT, Basterfield L, McCleave PM, et al. Gamma-Aminobutyric acid (GABA) transport across human intestinal epithelial (Caco-2) cell monolayers. Br J Pharmacol. 2000;129:457-464.
15. Hayakawa K, Kimura M, Kasaha K, et al. Effect of a (-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Nutr. 2007;92:411-417.
16. Yamakoshi J, Fukuda S, Satoh T, et al. Antihypertensive and natriuretic effects of less-sodium soy sauce containing g-aminobutyric acid in spontaneously hypertensive rats. Biosci Biotechnol Biochem. 2007;71:165-173.
17. Liu CF, Tung YT, Wu CL, et al. Antihypertensive effects of Lactobacillus-fermented milk orally administered to spontaneously hypertensive rats. J Agric Food Chem. 2011;59:4537-4543.
18. Yoshimura M, Toyoshi T, Sano A, et al. Antihypertensive effect of a gamma-aminobutyric acid rich tomato cultivar ''DG03-9'' in spontaneously hypertensive rats. J Agric Food Chem. 2010;58: 615-619.
19. Pouliot-Mathieu K, Gardner-Fortier C, Lemieux S, et al. Effect of cheese containing gamma-aminobutyric acid-producing lactic acid bacteria on blood pressure in men. PharmaNutrition. 2013;1: 141-148.
20. Shimada M, Hasegawa T, Nishimura C, et al. Anti-hypertensive effect of g-aminobutyric acid (GABA)-rich chlorella on high-normal blood pressure and borderline hypertension in placebo-controlled double blind study. 2009;31:342-354
21. Tanaka H, Watanabe K, Ma M, et al. The effects of gammaaminobutyric acid, vinegar, and dried bonito on blood pressure in normotensive and mildly or moderately hypertensive volunteers. J Clin Biochem Nutr. 2009;45:93-100.
22. Nishimura M, Yoshida S, Haramoto M, et al. Effects of white rice containing enriched gamma-aminobutyric acid on blood pressure. J Tradit Complement Med. 2015doi: 10.1016/j.jtcme.2014.11.022.
23. Inoue K, Shirai T, Ochiai H, et al. Blood-pressure-lowering effect of a novel fermented milk containing g-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr. 2003;57:490-495.
24. Braun M, Ramracheya R, Bengtsson M, et al. y-Aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic b-cells. Diabetes. 2010;59:1694-1701.
25. Adeghate E, Ponery AS. GABA in the endocrine pancreas: cellular localization and function in normal and diabetic rats. Tissue Cell. 2002;34:1-6.
26. Martnez-Maqueda D, Miralles B, Recio I, et al. Antihypertensive peptides from food proteins: a review. Food Funct. 2012;3:350-361.
27. Turpeinen AM, Järvenpää S, Kautiainen H, et al. Antihypertensive effects of bioactive tripeptides-a random effects meta-analysis. Ann Med. 2013;45:51-56.
28. Qin L-Q, Xu J-Y, Dong J-Y, et al. Lactotripeptides intake and blood pressure management: a meta-analysis of randomised controlled clinical trials. Nutr Metab Cardiovasc Dis. 2013;23:395-402.
29. Cicero AFG, Gerocarni B, Laghi L, et al. Blood pressure lowering effect of lactotripeptides assumed as functional foods: a metaanalysis of current available clinical trials. J Hum Hypertens. 2011;25:425-436.
30. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
31. Organization WH. Human energy requirements: report of a joint FAO/WHO/UNU Expert Consultation, Rome 17-24 October 2001. Rome: Food Agric Organ United Nations; 2004.
32. Diana M, Tres A, Qúlez J, et al. Spanish cheese screening and selection of lactic acid bacteria with high gamma-aminobutyric acid production. LWT-Food Sci Technol. 2014;56:351-355.
33. Peñas E, Diana M, Frias J, et al. A multistrategic approach in the development of sourdough bread targeted towards blood pressure reduction. Plant Foods Hum Nutr. 2015;70:97-103.
34. O'Brien E, Parati G, Stergiou G. Ambulatory blood pressure measurement: what is the international consensus? Hypertension. 2013;62:988-994.
35. Mataix VJ. Tabla de composicion de alimentos [food composition tables]. 4th ed. Granada, Spain: Universidad de Granada; 2003.
36. Elosua R, Marrugat J, Molina L, et al. Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish men. The MARATHOM Investigators. Am J Epidemiol. 1994;139:1197-1209.
37. Ferré R, Plana N, Merino J, et al. Effects of therapeutic lifestyle changes on peripheral artery tonometry in patients with abdominal obesity. Nutr Metab Cardiovasc Dis. 2012;22:95-102.
38. Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascula. J Am Soc Echocardiogr. 2008;21:93-111quiz 189-190.
39. Junyent M, Gilabert R, Núñez I, et al. [Carotid ultrasound in the assessment of preclinical atherosclerosis. Distribution of intimamedia thickness values and plaque frequency in a Spanish community cohort]. Med Clin (Barc). 2005;125:770-774.
40. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
41. Cook NR. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995;155: 701-709.
42. Hayakawa K, Kimura M, Kamata K. Mechanism underlying gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. Eur J Pharmacol. 2002;438: 107-113.
43. Cavagnini F, Pinto M, Dubini A, et al. Effects of gamma aminobutyric acid (GABA) and muscimol on endocrine pancreatic function in man. Metabolism. 1982;31:73-77.
44. Ferré R, Aragonès G, Plana N, et al. High-density lipoprotein cholesterol and apolipoprotein A1 levels strongly influence the reactivity of small peripheral arteries. Atherosclerosis. 2011;216:115-119.
45. Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008;117:2467-2474.
46. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J. 2010;31:1142-1148.
47. Parati G, Stergiou G, O'Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359-1366.
48. Alderson P. Absence of evidence is not evidence of absence. BMJ. 2004;328:476-477.